Low Prevalence of Anti-HBc Antibody and Lack of HBV DNA Among HBsAg-Negative Blood Donors in Iran: A Cross-sectional Study and Review of Literature. [PDF]
Hedayati-Moghaddam MR +4 more
europepmc +1 more source
The Effect of Low HBV-DNA Viral Load on Recurrence in Hepatocellular Carcinoma Patients Who Underwent Primary Locoregional Treatment and the Development of a Nomogram Prediction Model. [PDF]
Xiong Y, Wang Z, Liu J, Li K, Zhang Y.
europepmc +1 more source
[Is it appropriate for the "Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)" to require HBeAg-negative chronic HBV-infected patients to be HBV DNA-negative?] [PDF]
Liu M, Zhao TX, Geng JW.
europepmc +1 more source
[Changes in serum HBV-DNA in various types of HBV infection and their clinical significance].
openaire +2 more sources
[Detection of HBV DNA by the in situ hybridization method].
openaire +2 more sources
Related searches:
The safety of the blood supply has been greatly improved in the past two decades owing to continuous improvement in the technology and sensitivity of laboratory testing, better donor education and selection, and tighter quality control on blood bank operations.
openaire +2 more sources
AbstractThe role of hepatitis B virus (HBV) in carcinogenesis of hepatitis B surface antigen (HBsAg)‐negative, anti‐hepatitis C virus (anti‐HCV)‐positive hepatocellular carcinoma (HCC) remains unknown. To investigate the state of HBV DNA in such HCC, HBV DNA was examined by polymerase chain reaction (PCR) between HBV DNA and human Alu sequence (HBV‐Alu
S, Kawai +4 more
openaire +2 more sources
Studies on the structure of HBV DNA.
Science in China. Series B, Chemistry, life sciences & earth sciences, 1989The structure of HBV adr NC-1 DNA is analyzed and compared with another five strains of HBV DNAs. Some of the prokaryotic promoter-like sequences, palindrom sequences and ATAA are found. An enhancer core sequence and some other characteristics are also shown.
Qi, ZH, Yan, J, Zhu, QL
openaire +3 more sources
A novel, small anti-HBV compound reduces HBsAg and HBV-DNA by destabilizing HBV-RNA
Journal of GastroenterologyCurrently, standard treatments for chronic hepatitis B such as nucleos(t)ide analogs (NAs), effectively reduce hepatitis B virus (HBV) loads but rarely result in a functional cure (defined as sustained HBsAg loss). We report the discovery of a novel, 4-pyridone compound, SAG-524, a potent and orally bioavailable small molecule inhibitor of HBV ...
Takehisa Watanabe +6 more
openaire +2 more sources
STUDY OF HBEAG, HBV DNA IN PATIENTS WITH HBV- RELATED CIRRHOSIS
Journal of Medicine and Pharmacy, 2012Background: The recent studies concerning antiviral therapy in HBV-related cirrhosis showed the promising results. This study aimed to assess /The aim of this study was to assess the quantity of HBeAg, HBV DNA and identify some related factors in patients with HBV-induced cirrhosis.
Van Huy Tran +2 more
openaire +1 more source

